Agreement Reached on Primary Endpoint and Phase 3 Trial Design. Oral APX3330 is a Late-Stage Clinical Asset Available for Partnering. FARMINGTON HILLS, Mich., Dec. 19, 2024 (GLOBE ...
The UNCCD COP16 concluded with a renewed focus on building drought resilience globally, but failed to agree on bringing a legally binding drought protocol.